ASTHMA IN SAUDI ARABIA: RISK FACTORS AND PHARMACOTHERAPY

Mohamed A. Hammad, M and Khaled M. Alakhali, K and Manal Hattan, M and Dzul Azri Mohamed Noor, D and Syed Azhar Syed Sulaiman, S and Abeer M. Kharshid, A and Ahmed A. Khamis, A (2016) ASTHMA IN SAUDI ARABIA: RISK FACTORS AND PHARMACOTHERAPY. Indo American Journal of Pharmaceutical Research, 6 (11). pp. 6814-6821. ISSN 2231-6876

[img]
Preview
PDF
28.ASTHMA IN SAUDI ARABIA RISK FACTORS AND PHARMACOTHERAPY (2).pdf

Download (744kB) | Preview
Official URL: http://www.iajpr.com/archive/volume-6/nov-2016/16n...

Abstract

Asthma is a chronic disease of airways; that is widely characterized by an increased responsiveness to a large variety of stimuli, airway inflammation and obstruction. Responsiveness to the treatment of asthma is good but sometimes resistance develops, and variability in symptoms also occurs due to the limited therapy adherence and awareness of patients. A cross-sectional survey was conducted at Armed Forces Hospital Southern Region, Khamis Mushait, Kingdom of Saudi Arabia, May 2014, to evaluate the risk factors of asthma and the pharmacotherapy used by patients. A self-administered questionnaire was answered by 207 asthmatic people aged ≥15 years. They responded to questions regarding demographics, risk factors for asthma, its severity, drug used for asthma therapy. Most of the asthma risk factors are an allergy (71.5%), and family history (60.9%). Some patients, especially the elderly use non-steroidal anti-inflammatory (26.5%) and aspirin (5.8%). Most of the asthmatic patients had mild intermittent asthma (69.6%). Patients used an inhaler (61.4%), most of them prefer to use Ventolin inhaler (78.3%) and the majority of them non-compliance for pharmacotherapy (76%). Subjects in past month got shortness of breath once or twice in a week (61.4%). Patients wake up once or twice during the month because of asthma symptoms (20.3%). Nearly half of them have increased symptoms of asthma in winter (56.5%), and less than half of cases had proper control of asthma (48.3%). The majority of patients were non-compliance and used Ventolin. Most of respondents had allergy and family history of asthma.

Item Type: Article
Subjects: Pharmacy
Divisions: College of Pharmacy > Pharmacy
Depositing User: KHALED ALAKHALI
Date Deposited: 05 Jun 2017 09:09
Last Modified: 05 Jun 2017 09:09
URI: http://eprints.kku.edu.sa/id/eprint/912

Actions (login required)

View Item View Item